Nathalie Wunderlich

657 total citations
17 papers, 554 citations indexed

About

Nathalie Wunderlich is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Nathalie Wunderlich has authored 17 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Nathalie Wunderlich's work include Virus-based gene therapy research (6 papers), Acute Ischemic Stroke Management (6 papers) and Cancer Research and Treatments (5 papers). Nathalie Wunderlich is often cited by papers focused on Virus-based gene therapy research (6 papers), Acute Ischemic Stroke Management (6 papers) and Cancer Research and Treatments (5 papers). Nathalie Wunderlich collaborates with scholars based in Germany, United States and Japan. Nathalie Wunderlich's co-authors include Christine Spitzweg, Michael J. Willhauck, Burkhard Göke, Gerhard F. Hamann, Christian Zach, Kathrin Klutz, Dorothe Burggraf, Martin Liebetrau, Ernst Wagner and Reingard Senekowitsch–Schmidtke and has published in prestigious journals such as Stroke, Clinical Cancer Research and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Nathalie Wunderlich

17 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathalie Wunderlich Germany 13 265 140 99 92 83 17 554
Takashi Kon Japan 12 214 0.8× 59 0.4× 82 0.8× 60 0.7× 40 0.5× 37 443
M.A. Witlox Netherlands 13 312 1.2× 122 0.9× 96 1.0× 165 1.8× 32 0.4× 21 555
Ana Pestana Portugal 14 197 0.7× 50 0.4× 54 0.5× 98 1.1× 39 0.5× 26 469
Abram Vaccaro United States 8 314 1.2× 42 0.3× 50 0.5× 172 1.9× 15 0.2× 14 523
Daniel H. Y. Shen Taiwan 11 152 0.6× 98 0.7× 27 0.3× 64 0.7× 20 0.2× 19 498
Wenli Qian China 9 356 1.3× 42 0.3× 117 1.2× 110 1.2× 32 0.4× 17 557
H. Roché France 12 177 0.7× 48 0.3× 102 1.0× 250 2.7× 73 0.9× 35 596
Akira Muramatsu Japan 13 219 0.8× 86 0.6× 30 0.3× 71 0.8× 16 0.2× 23 545
Tullio Battista Italy 9 240 0.9× 53 0.4× 54 0.5× 131 1.4× 13 0.2× 11 532
A. Larsen Denmark 10 150 0.6× 41 0.3× 59 0.6× 293 3.2× 17 0.2× 18 617

Countries citing papers authored by Nathalie Wunderlich

Since Specialization
Citations

This map shows the geographic impact of Nathalie Wunderlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Wunderlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Wunderlich more than expected).

Fields of papers citing papers by Nathalie Wunderlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathalie Wunderlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Wunderlich. The network helps show where Nathalie Wunderlich may publish in the future.

Co-authorship network of co-authors of Nathalie Wunderlich

This figure shows the co-authorship network connecting the top 25 collaborators of Nathalie Wunderlich. A scholar is included among the top collaborators of Nathalie Wunderlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalie Wunderlich. Nathalie Wunderlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Klutz, Kathrin, Nathalie Wunderlich, Alexandra Vetter, et al.. (2011). Transferrin-receptor (Tfr) targeted, systemic sodium iodide symporter (NIS) gene delivery in liver cancer. 1 indexed citations
2.
Klutz, Kathrin, David Schaffert, Michael J. Willhauck, et al.. (2011). Epidermal Growth Factor Receptor-targeted 131I-therapy of Liver Cancer Following Systemic Delivery of the Sodium Iodide Symporter Gene. Molecular Therapy. 19(4). 676–685. 90 indexed citations
3.
Klutz, Kathrin, Michael J. Willhauck, Nathalie Wunderlich, et al.. (2011). Image-guided, Tumor Stroma-targeted 131I Therapy of Hepatocellular Cancer After Systemic Mesenchymal Stem Cell-mediated NIS Gene Delivery. Molecular Therapy. 19(9). 1704–1713. 72 indexed citations
4.
Klutz, Kathrin, Michael J. Willhauck, Christian Dohmen, et al.. (2011). Image-Guided Tumor-Selective Radioiodine Therapy of Liver Cancer After Systemic Nonviral Delivery of the Sodium Iodide Symporter Gene. Human Gene Therapy. 22(12). 1563–1574. 40 indexed citations
5.
Klutz, Kathrin, Michael J. Willhauck, Nathalie Wunderlich, et al.. (2011). Sodium Iodide Symporter (NIS)-Mediated Radionuclide ( 131 I, 188 Re) Therapy of Liver Cancer After Transcriptionally Targeted Intratumoral in Vivo NIS Gene Delivery. Human Gene Therapy. 22(11). 1403–1412. 44 indexed citations
6.
Willhauck, Michael J., et al.. (2010). Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of 131I by carbamazepine in breast cancer cells. Breast Cancer Research and Treatment. 125(2). 377–386. 13 indexed citations
7.
Klutz, Kathrin, Verena Ruß, Michael J. Willhauck, et al.. (2009). Targeted Radioiodine Therapy of Neuroblastoma Tumors following Systemic Nonviral Delivery of the Sodium Iodide Symporter Gene. Clinical Cancer Research. 15(19). 6079–6086. 59 indexed citations
8.
Willhauck, Michael J., Reingard Senekowitsch–Schmidtke, Nathalie Wunderlich, et al.. (2007). Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. Breast Cancer Research and Treatment. 109(2). 263–272. 26 indexed citations
9.
Burggraf, Dorothe, Martin Liebetrau, Nathalie Wunderlich, et al.. (2006). Influence of the duration of ischemia and reperfusion on infarct volume and microvascular damage in mice. Neurological Research. 28(2). 200–205. 11 indexed citations
10.
Voško, Milan R., et al.. (2006). Pravastatin reduces microvascular basal lamina damage following focal cerebral ischemia and reperfusion. European Journal of Neuroscience. 24(2). 520–526. 27 indexed citations
11.
Liebetrau, Martin, et al.. (2005). ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats. Neuroscience Letters. 376(3). 205–209. 18 indexed citations
12.
Burggraf, Dorothe, Martin Liebetrau, Helge Martens, et al.. (2005). Matrix metalloproteinase induction by EMMPRIN in experimental focal cerebral ischemia. European Journal of Neuroscience. 22(1). 273–277. 24 indexed citations
13.
Burggraf, Dorothe, et al.. (2005). Recombinant tissue plasminogen activator attenuates basal lamina antigen loss after experimental focal cerebral ischemia. Neurological Research. 27(2). 212–217. 5 indexed citations
14.
Burggraf, Dorothe, et al.. (2004). Rt‐PA causes a significant increase in endogenous u‐PA during experimental focal cerebral ischemia. European Journal of Neuroscience. 20(11). 2903–2908. 7 indexed citations
15.
Hamann, Gerhard F., Dorothe Burggraf, Helge Martens, et al.. (2004). Mild to Moderate Hypothermia Prevents Microvascular Basal Lamina Antigen Loss in Experimental Focal Cerebral Ischemia. Stroke. 35(3). 764–769. 89 indexed citations
16.
Hamann, Gerhard F., Helmut Schröck, Dorothe Burggraf, et al.. (2003). Microvascular Basal Lamina Damage after Embolic Stroke in the Rat: Relationship to Cerebral Blood Flow. Journal of Cerebral Blood Flow & Metabolism. 23(11). 1293–1297. 13 indexed citations
17.
Loy, M., Dorothe Burggraf, Martin Liebetrau, et al.. (2002). A gelatin in situ-overlay technique localizes brain matrix metalloproteinase activity in experimental focal cerebral ischemia. Journal of Neuroscience Methods. 116(2). 125–133. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takashi Kon Breakdown of academic impact, for papers by M.A. Witlox Breakdown of academic impact, for papers by Ana Pestana Breakdown of academic impact, for papers by Abram Vaccaro Breakdown of academic impact, for papers by Daniel H. Y. Shen Breakdown of academic impact, for papers by Wenli Qian Breakdown of academic impact, for papers by H. Roché Breakdown of academic impact, for papers by Akira Muramatsu Breakdown of academic impact, for papers by Tullio Battista Breakdown of academic impact, for papers by A. Larsen
Rankless by CCL
2026